Aarti Drugs Limited (AARTIDRUGS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 29.18B |
| Enterprise Value | 34.86B |
| P/E Ratio | 20.29 |
| PEG Ratio | 1.35 |
| Price/Sales Ratio | 1.63 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 1.84 |
| Enterprise/EBITDA | 13.64 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 25.65B |
| Revenue/Share | 312.37 |
| Gross Profit | 7.5B |
| EBITDA | 3.12B |
| Net Income | 1.95B |
| Diluted EPS | 21.36 |
Balance Sheet
| Total Cash | 99.5M |
| Total Cash/Share | 1.09 |
| Total Debt | 6.2B |
| Total Debt/Equity | 0.37 |
| Current Ratio | 1.59 |
| Book Value Per Share | 184.26 |
Price History
| 52-Week Change | 7.11 |
| 52-Week High | 514.1 |
| 52-Week Low | 318.95 |
| Moving Average 50 Days | 427.33 |
| Moving Average 200 Days | 392.61 |
Statistics
| Average Volume | 847,514 |
| Shares Outstanding | 91.27M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 0.39 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | September 30, 2020 |
AD
